Antengene Submits New Drug Application for Selinexor in Taiwan for the Treatment of Three Indications in Hematologic Malignancies ...Middle East

SHANGHAI and HONG KONG, July 13, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology...

Hence then, the article about antengene submits new drug application for selinexor in taiwan for the treatment of three indications in hematologic malignancies was published today ( Wednesday 14/07/2021 - 05:00 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Antengene Submits New Drug Application for Selinexor in Taiwan for the Treatment of Three Indications in Hematologic Malignancies )

Also on site :

• Not to be dramatic, but LEGO Batman: Legacy of the Dark Knight might be the best Batman game ever
• 15 Shows Like 'Widow's Bay' You Should Watch Next
• This is what super powers must learn from US’ war against Iran